The FDA has authorized 20 ZYN nicotine pouch products to be marketed with claims that they pose a lower health risk than traditional cigarettes. The agency says adults who completely switch from cigarettes to ZYN may reduce their risk of serious smoking-related diseases, including lung cancer, heart disease, stroke, emphysema, and chronic bronchitis.
Public health groups have raised concerns about the growing popularity of flavored nicotine pouches among younger users, while supporters argue the products provide smokers with a less harmful alternative to cigarettes
